M Moshkowitz

Summary

Country: Italy

Publications

  1. ncbi Risk factors for severity and relapse of pseudomembranous colitis in an elderly population
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel
    Colorectal Dis 9:173-7. 2007
  2. ncbi Increased leukocyte adhesiveness/aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation
    N Arber
    Department of Gastroenterology, Tel Aviv Medical Center Ichilov Hospital, Sackler Faculty of Medicine, Tel Aviv University, Israel
    Dis Colon Rectum 39:632-5. 1996
  3. ncbi Activation of c-K-ras mutations in human gastrointestinal tumors
    N Arber
    GI Oncology Unit, Tel Aviv University, Tel Aviv, Israel
    Gastroenterology 118:1045-50. 2000
  4. ncbi Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patients
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Isr Med Assoc J 2:892-5. 2000
  5. ncbi Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice
    N Horowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Aliment Pharmacol Ther 26:1277-83. 2007
  6. ncbi A novel device for rapid cleaning of poorly prepared colons
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Endoscopy 42:834-6. 2010
  7. ncbi Rofecoxib reduces polyp recurrence in familial polyposis
    A Hallak
    Gastrointestinal Oncology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Dig Dis Sci 48:1998-2002. 2003
  8. ncbi Halitosis and gastroesophageal reflux disease: a possible association
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Oral Dis 13:581-5. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Risk factors for severity and relapse of pseudomembranous colitis in an elderly population
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel
    Colorectal Dis 9:173-7. 2007
    ..To evaluate the outcome of elderly patients with PMC, and to try to identify risk factors that might influence mortality or relapse...
  2. ncbi Increased leukocyte adhesiveness/aggregation in patients with inflammatory bowel disease during remission. Further evidence for subclinical inflammation
    N Arber
    Department of Gastroenterology, Tel Aviv Medical Center Ichilov Hospital, Sackler Faculty of Medicine, Tel Aviv University, Israel
    Dis Colon Rectum 39:632-5. 1996
    ..We have used a novel leukocyte adhesiveness/aggregation test (LAAT) to show that many patients with inflammatory bowel disease (IBD) in clinical remission have a subclinical low grade inflammation...
  3. ncbi Activation of c-K-ras mutations in human gastrointestinal tumors
    N Arber
    GI Oncology Unit, Tel Aviv University, Tel Aviv, Israel
    Gastroenterology 118:1045-50. 2000
    ..Ras genes are the most frequently detected oncogenes in human malignancies. Data regarding the frequency of c-K-ras mutations in esophageal, gastric, and small bowel tumors are limited and controversial...
  4. ncbi Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patients
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Isr Med Assoc J 2:892-5. 2000
    ..Cigarette smoking has long been regarded as an important factor in the pathogenesis of peptic ulcer disease...
  5. ncbi Clinical trial: evaluation of a clinical decision-support model for upper abdominal complaints in primary-care practice
    N Horowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Aliment Pharmacol Ther 26:1277-83. 2007
    ....
  6. ncbi A novel device for rapid cleaning of poorly prepared colons
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Endoscopy 42:834-6. 2010
    ..The aim of this study was to assess the efficacy and safety of a novel attachable colon-cleaning device used during colonoscopies in porcine colon...
  7. ncbi Rofecoxib reduces polyp recurrence in familial polyposis
    A Hallak
    Gastrointestinal Oncology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Dig Dis Sci 48:1998-2002. 2003
    ..016 and 0.008, respectively). No patient developed cancer or high-grade adenoma. In conclusion, Long-term use of rofecoxib is well tolerated and effective in inhibiting polyp formation in polyposis patients...
  8. ncbi Halitosis and gastroesophageal reflux disease: a possible association
    M Moshkowitz
    Department of Gastroenterology, Tel Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Oral Dis 13:581-5. 2007
    ..Previous reports have suggested that gastrointestinal (GI) diseases may cause halitosis. The aim of this study was to evaluate the relationship between upper GI conditions, especially gastroesophageal reflux disease (GERD), and halitosis...